AAAAAA

   
Results: 1-10 |
Results: 10

Authors: von Gegerfelt, AS Liska, V Li, PL McClure, HM Horie, K Nappi, F Montefiori, DC Pavlakis, GN Marthas, ML Ruprecht, RM Felber, BK
Citation: As. Von Gegerfelt et al., Rev-independent simian immunodeficiency virus strains are nonpathogenic inneonatal macaques, J VIROLOGY, 76(1), 2002, pp. 96-104

Authors: Marthas, ML Lu, D Penedo, MCT Hendrickx, AG Miller, CJ
Citation: Ml. Marthas et al., Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: Transmission efficiency, viral loads, and antibody responses, AIDS RES H, 17(15), 2001, pp. 1455-1466

Authors: Greenier, JL Miller, CJ Lu, D Dailey, PJ Lu, FX Kunstman, KJ Wolinsky, SM Marthas, ML
Citation: Jl. Greenier et al., Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques, J VIROLOGY, 75(8), 2001, pp. 3753-3765

Authors: Van Rompay, KKA McChesney, MB Aguirre, NL Schmidt, KA Bischofberger, N Marthas, ML
Citation: Kka. Van Rompay et al., Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection, J INFEC DIS, 184(4), 2001, pp. 429-438

Authors: Van Rompay, KKA Miller, MD Marthas, ML Margot, NA Dailey, PJ Canfield, DR Tarara, RP Cherrington, JM Aguirre, NL Bischofberger, N Pedersen, NC
Citation: Kka. Van Rompay et al., Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA, J VIROLOGY, 74(4), 2000, pp. 1767-1774

Authors: Van Rompay, KKA Marthas, ML
Citation: Kka. Van Rompay et Ml. Marthas, Nonhuman primate models for testing anti-HIV drugs, ANTIVIRALS AGAINST AIDS, 2000, pp. 295-320

Authors: Tarantal, AF Marthas, ML Shaw, JP Cundy, K Bischofberger, N
Citation: Af. Tarantal et al., Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): Safety and efficacy studies, J ACQ IMM D, 20(4), 1999, pp. 323-333

Authors: Van Rompay, KKA Cherrington, JM Marthas, ML Lamy, PD Dailey, PJ Canfield, DR Tarara, RP Bischofberger, N Pedersen, NC
Citation: Kka. Van Rompay et al., 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA, ANTIM AG CH, 43(4), 1999, pp. 802-812

Authors: Van Rompay, KKA Dailey, PJ Tarara, RP Canfield, DR Aguirre, NL Cherrington, JM Lamy, PD Bischofberger, N Pedersen, NC Marthas, ML
Citation: Kka. Van Rompay et al., Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques, J VIROLOGY, 73(4), 1999, pp. 2947-2955

Authors: Luciw, PA Shaw, KES Shacklett, BL Marthas, ML
Citation: Pa. Luciw et al., Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis, VIROLOGY, 252(1), 1998, pp. 9-16
Risultati: 1-10 |